Pfizer's latest marketcap:
As of 07/30/2025, Pfizer's market capitalization has reached $138.15 B. According to our data, Pfizer is the 130th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 138.15 B |
| Revenue (ttm) | 62.46 B |
| Net Income (ttm) | 7.88 B |
| Shares Out | 5.69 B |
| EPS (ttm) | 1.38 |
| Forward PE | 8.56 |
| Ex-Dividend Date | 07/25/2025 |
| Earnings Date | 08/05/2025 |
Pfizer's yearly market capitalization.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 07/30/2025 | $138.15 B | -8.07% | 130 |
| 12/31/2024 | $150.35 B | -7.51% | 95 |
| 12/29/2023 | $162.56 B | -43.48% | 73 |
| 12/30/2022 | $287.63 B | -13.22% | 28 |
| 12/31/2021 | $331.44 B | 61.99% | 26 |
| 12/31/2020 | $204.6 B | -5.64% | 45 |
| 12/31/2019 | $216.83 B | -14.07% | 37 |
| 12/31/2018 | $252.32 B | 16.87% | 15 |
| 12/29/2017 | $215.9 B | 9.54% | 28 |
| 12/30/2016 | $197.1 B | -1.09% | 26 |
Company Profile
Pfizer Inc. Overview
Pfizer Inc. is a global biopharmaceutical company engaged in the discovery, development, manufacturing, and commercialization of medicines and vaccines. Headquartered in New York, the company serves healthcare providers, wholesalers, and government agencies worldwide.
Key Therapeutic Areas & Brands
- Cardiovascular & Migraine: Eliquis, Nurtec ODT/Vydura, Zavzpret, Premarin family
- Infectious Diseases: Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, Trumenba
- COVID-19 Solutions: Comirnaty, Paxlovid (with potential mRNA and antiviral developments)
- Chronic Immune & Inflammatory Diseases: Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, Cibinqo
- Rare Diseases & Endocrinology: Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, Genotropin
- Sterile Injectables & Anti-Infectives: Sulperazon, Medrol, Zavicefta, Zithromax, Octagam, Panzyga
- Oncology & Biosimilars: Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, Talzenna
Business Segments
In addition to its core pharmaceutical operations, Pfizer is involved in contract manufacturing, supplying products to hospitals, clinics, pharmacies, and integrated delivery systems.
Strategic Collaborations
The company partners with leading healthcare organizations, including:
- Bristol-Myers Squibb Company
- Astellas Pharma US, Inc.
- Merck KGaA
- BioNTech SE
Founded: 1849 | Headquarters: New York, New York
Frequently Asked Questions
-
What is Pfizer's (PFE) current market cap?As of 07/30/2025, Pfizer (including the parent company, if applicable) has an estimated market capitalization of $138.15 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Pfizer (PFE) rank globally by market cap?Pfizer global market capitalization ranking is approximately 130 as of 07/30/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.